Erratum: High expressions of vascular endothelial growth factor and platelet-derived endothelial cell growth factor predict poor prognosis in alpha-fetoprotein-negative hepatocellular carcinoma patients after curative resection (Journal of Cancer Research and Clinical Oncology DOI: 10.1007/s00432-009-0577-5);High expressions of vascular endothelial growth factor and platelet-derived endothelial cell growth factor predict poor prognosis in alpha-fetoprotein- negative hepatocellular carcinoma patients after curative resection

Journal of Cancer Research and Clinical Oncology

Volumn 135, Issue 10, 2009, Pages 1359-1367

  Hu, Jie ^a   Xu, Yang ^a   Shen, Zao Zhuo ^a   Wang, Zheng ^a   Lu, Qing ^a   Yang, Guo Huan ^a   Ding, Zheng Bin ^a   Fan, Jia ^a   Zhou, Jian ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Platelet derived endothelial cell growth factor; Prognosis; Tissue microarrays; Vascular endothelial growth factor

Indexed keywords

ALPHA FETOPROTEIN; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CANCER TISSUE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RELAPSE; TISSUE MICROARRAY;

EID: 69049116144     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-009-0663-8     Document Type: Erratum

References (41)

1. GK Abou-Alfa L Schwartz S Ricci, et al. 2006 Phase II study of sorafenib in patients with advanced hepatocellular carcinoma J Clin Oncol 24 4293 4300 10.1200/JCO.2005.01.3441
2. RL Baron G Brancatelli 2004 Computed tomographic imaging of hepatocellular carcinoma Gastroenterology 127 S133 S143 10.1053/j.gastro.2004. 09.027
3. B Berse LF Brown L Van de Water, et al. 1992 Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors Mol Biol Cell 3 211 220
4. FX Bosch J Ribes R Cleries, et al. 2005 Epidemiology of hepatocellular carcinoma Clin Liver Dis 9 191 211 10.1016/j.cld.2004.12.009
5. Y Chao CP Li GY Chau, et al. 2003 Prognostic significance of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin in patients with resectable hepatocellular carcinoma after surgery Ann Surg Oncol 10 355 362 10.1245/ASO.2003.10.002
6. G Chen W Lin F Shen, et al. 2006 Past HBV viral load as predictor of mortality and morbidity from HCC and chronic liver disease in a prospective study Am J Gastroenterol 101 1797 1803 10.1111/j.1572-0241.2006.00647.x
7. B Daniele A Bencivenga AS Megna, et al. 2004 Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma Gastroenterology 127 S108 S112 10.1053/j.gastro.2004.09.023
8. G Deli CH Jin R Mu, et al. 2005 Immunohistochemical assessment of angiogenesis in hepatocellular carcinoma and surrounding cirrhotic liver tissues World J Gastroenterol 11 960 963
9. HA Edmondson PE Steiner 1954 Primary carcinoma of the liver: a study of 100 cases among 48, 900 necropsies Cancer 7 462 503 10.1002/1097-0142(195405)7: 3<462::AID-CNCR2820070308>3.0.CO;2-E
10. N Ferrara 2001 Role of vascular endothelial growth factor in regulation of physiological angiogenesis Am J Physiol Cell Physiol 280 C1358 C1366
11. J Folkman 2002 Role of angiogenesis in tumor growth and metastasis Semin Oncol 29 15 18
12. J Folkman Y Shing 1992 Angiogenesis J Biol Chem 267 10931 10934
13. L Guo N Kuroda M Toi, et al. 2001 Increased expression of platelet-derived endothelial cell growth factor in human hepatocellular carcinomas correlated with high Edmondson grades and portal vein tumor thrombosis Oncol Rep 8 871 876
14. M Haraguchi K Miyadera K Uemura, et al. 1994 Angiogenic activity of enzymes Nature 368 198 10.1038/368198a0
15. L Hu SH Lau CH Tzang, et al. 2004 Association of vimentin overexpression and hepatocellular carcinoma metastasis Oncogene 23 298 302 10.1038/sj.onc. 1207150
16. PJ Johnson 2001 The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma Clin Liver Dis 5 145 159 10.1016/S1089-3261(05)70158-6
17. XM Li ZY Tang LX Qin, et al. 1999 Serum vascular endothelial growth factor is a predictor of invasion and metastasis in hepatocellular carcinoma J Exp Clin Cancer Res 18 511 517
18. D Li T Mallory S Satomura 2001 AFP-L3: a new generation of tumor marker for hepatocellular carcinoma Clin Chim Acta 313 15 19 10.1016/S0009-8981(01) 00644-1
19. WC Liu JH Lim CK Park, et al. 2003 Poor sensitivity of sonography in detection of hepatocellular carcinoma in advanced liver cirrhosis: accuracy of pretransplantation sonography in 118 patients Eur Radiol 13 1693 1698 10.1007/s00330-002-1814-3
20. JM Llovet S Ricci V Mazzaferro, et al. 2008 Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 378 390 10.1056/NEJMoa0708857
21. J Mattern R Koommagi M Volm 1999 Biological characterization of subgroups of squamous cell lung carcinomas Clin Cancer Res 5 1459 1463
22. IO Ng RT Poon JM Lee, et al. 2001 Microvessel density, vascular endothelial growth factor and its receptors Flt-1and Flk-1/KDR in hepatocellular carcinoma Am J Clin Pathol 116 838 845 10.1309/FXNL-QTN1-94FH-AB3A
23. W Nolte H Hartmann G Ramadori, et al. 1995 Glucose metabolism and liver cirrhosis Exp Clin Endocrinol Diabetes 103 63 74
24. JH Park KC Koh MS Choi, et al. 2006 Analysis of risk factors associated with early multinodular recurrences after hepatic resection for hepatocellular carcinoma Am J Surg 192 29 33 10.1016/j.amjsurg.2005.11.010
25. SY Peng WJ Chen PL Lai, et al. 2004 High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations Int J Cancer 112 44 50 10.1002/ijc.20279
26. RT Poon IO Ng C Lau, et al. 2001 Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective study Ann Surg 233 227 235 10.1097/00000658-200102000-00012
27. RT Poon JW Ho CS Tong, et al. 2004 Prognostic significance of serum vascular endothelial growth factor and endostatin in patients with hepatocellular carcinoma Br J Surg 91 1354 1360 10.1002/bjs.4594
28. M Schmitt A Horbach R Kubitz, et al. 2004 Disruption of hepatocellular tight junctions by vascular endothelial growth factor (VEGF): a novel mechanism for tumor invasion J Hepatol 41 274 283 10.1016/j.jhep.2004.04.035
29. SA Shah SP Cleary AC Wei, et al. 2007 Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes Surgery 141 330 339 10.1016/j.surg.2006.06.028
30. K Shiraki K Takase Y Tameda, et al. 1995 A clinical study of lectin-reactive alpha-fetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patients Hepatology 22 802 807
31. K Taketa Y Endo C Sekiya, et al. 1993 A collaborative study for the evaluation of lectinreactive alpha-fetoproteins in early detection of hepatocellular carcinoma Cancer Res 53 5419 5423
32. ZY Tang SL Ye YK Liu, et al. 2004 A decade's studies on metastasis of hepatocellular carcinoma J Cancer Res Clin Oncol 130 187 196 10.1007/s00432-003-0511-1
33. M Toi T Matsumoto H Bando, et al. 2001 Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implications Lancet Oncol 2 667 673 10.1016/S1470-2045(01)00556-3
34. JG Tralhao I Dagher T Lino, et al. 2004 Treatment of tumour recurrence after resection of hepatocellular carcinoma. Analysis of 97 consecutive patients Eur J Surg Oncol 33 746 751 10.1016/j.ejso.2006.11.015
35. S Uematsu T Higashi K Nouso, et al. 2005 Altered expression of vascular endothelial growth factor, fibroblast growth factor-2 and endostatin in patients with hepatocellular carcinoma J Gastroenterol Hepatol 20 583 588 10.1111/j.1440-1746.2005.03726.x
36. C Valls M Cos J Figueras, et al. 2004 Pretransplantation diagnosis and staging of hepatocellular carcinoma in patients with cirrhosis: value of dual-phase helical CT AJR Am J Roentgenol 182 1011 1017
37. Y Yang H Nagano H Ota, et al. 2007 Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection Surgery 141 196 202 10.1016/j.surg.2006.06.033
38. GH Yang J Fan Y Xu, et al. 2008 Osteopontin combined with CD44, a novel prognostic biomarker for patients with hepatocellular carcinoma undergoing curative resection Oncologist 13 1155 1165 10.1634/theoncologist.2008-0081
39. H Yoshiji S Kuriyama DJ Hicklin, et al. 1999 KDR/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells Hepatology 30 1179 1186 10.1002/hep.510300509
40. J Zhou ZY Tang J Fa, et al. 2000 Expression of platelet-derived endothelial cell growth factor and vascular endothelial growth factor in hepatocellular carcinoma and portal vein tumor thrombus J Cancer Res Clin Oncol 126 57 61 10.1007/s004320050009
41. AX Zhu 2008 Development of sorafenib and other molecularly targeted agents in hepatocellular carcinoma Cancer 26 250 259